AI Article Synopsis
- Thymidine kinase 2 (TK2) is a key enzyme in mitochondria that helps process nucleoside analogs used in treatments for viral infections and cancer.
- * The study focused on fibroblast cells with less TK2 activity to understand how this affects nucleotide metabolism and drug sensitivity.
- * Findings indicate that cells lacking TK2 are still sensitive to certain nucleoside analogs, suggesting that TK2's role in activating these drugs may be less critical than that of other similar enzymes.
Article Abstract
Thymidine kinase 2 (TK2) is a mitochondrial deoxyribonucleoside kinase that phosphorylates several nucleoside analogs used in anti-viral and anti-cancer therapy. A fibroblast cell line with decreased TK2 activity was investigated in order to obtain insights in the effects of TK2 deficiency on nucleotide metabolism. The role of TK2 for the sensitivity against cytotoxic nucleoside analogs was also investigated. The TK2 deficient cells retained their sensitivity against all pyrimidine nucleoside analogs tested. This study suggests that nucleoside analog phosphorylation mediated by TK2 may be less important, compared to other deoxyribonucleoside kinases, for the cytotoxic effects of these compounds.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1080/15257770903454490 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!